albiglutide

A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .

Albiglutide Thorough ECG Study in Healthy Volunteers

Dose Ranging Study of Albiglutide in Japanese Subjects

Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

Safety and Efficacy of Albiglutide in Type 2 Diabetes

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus

Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects

An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus (Harmony Outcomes Trial, GLP116174)